Skip to main content
SpringerLink
Log in

Drug-Induced Orthostatic Hypotension in the Elderly

Avoiding its Onset

  • Review Articles
  • Pharmacoepidemiology
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

The prevalence of orthostatic hypotension in the elderly is reported to be 5 to 33%. This high prevalence contributes to the risk of syncope and falls in old age.

Drugs are a major cause of postural hypotension. Changes in pharmacokinetics and pharmacodynamics occur with aging in relation to many drugs, resulting in delayed elimination and increased bioavailability. Therefore, drugs with an antihypertensive action (diuretics, calcium antagonists, β-blockers, ACE inhibitors, α1-blockers, and centrally acting antihypertensives) have a more pronounced effect in the elderly. Nitrates, antiparkinsonian drugs, antidepressants and antipsychotics all cause hypotension as a known adverse effect.

When assessing orthostatic hypotension in the elderly, drug treatment should always be reviewed. Whenever possible, antihypertensive drugs should be discontinued, and the dosages of essential drugs should be reduced.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tilvis RS, Hakala S, Valvanne J, et al. Postural hypotension and dizziness in a general aged population: a four-year follow-up of the Helsinki Aging Study. J Am Geriatr Soc 1996; 44: 809–14

    PubMed  CAS  Google Scholar 

  2. Tonkin A, Wing L. Aging and susceptibility to drug-induced orthostatic hypotension. Clin Pharmacol Ther 1992; 52 (3): 277–85

    PubMed  CAS  Google Scholar 

  3. Zaleon CR, Guthrie SK. Antipsychotic drug use in older adults. Am J Hosp Pharm 1994; 51: 2917–43

    PubMed  CAS  Google Scholar 

  4. Raiha I, Luutonen S, Piha J, et al. Prevalence, predisposing factors, and prognostic importance of postural hypotension. Arch Intern Med 1995; 155: 930–5

    PubMed  CAS  Google Scholar 

  5. Palmer KT. Studies into postural hypotension in elderly patients. NZ Med J 1983; 96: 43–5

    CAS  Google Scholar 

  6. Mader SL, Josephson KR, Rubenstein LZ. Low prevalence of postural hypotension among community-dwelling elderly. JAMA 1987; 258: 1511–4

    PubMed  CAS  Google Scholar 

  7. Campbell AJ, Borrie MJ, Spears GF. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol 1989; 44: M112–7

    PubMed  CAS  Google Scholar 

  8. Robbins AS, Rubenstein LZ, Josephson KR, et al. Predictors of falls among elderly people: results of two population-based studies. Arch Intern Med 1989; 149: 1628–33

    PubMed  CAS  Google Scholar 

  9. Si M, Rodstein M, Neufeld RR, et al. Orthostatic change in blood pressure in non-demented, ambulatory nursing home patients. Arch Gerontol Geriatr 1992; 14: 123–9

    PubMed  CAS  Google Scholar 

  10. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults: the cardiovascular health study. Hypertension 1992; 19: 508–19

    PubMed  CAS  Google Scholar 

  11. Applegate WB, Davis BR, Black HR, et al. Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort. J Am Geriatr Soc 1991; 39: 1057–64

    PubMed  CAS  Google Scholar 

  12. Consensus Committee of the American Society and the American Academy of Neurology. Consensus Statement on the definition of orthostatic hypotension, pure autonomic failure and multiple systme atrophy. Neurology 1996; 46: 1470

    Google Scholar 

  13. Streeten DHP. Orthostatic disorders of the circulation. New York: Plenum, 1987

    Google Scholar 

  14. Lipsitz A. Orthostatic hypotension in the elderly. N Engl J Med 1989; 321: 952–7

    PubMed  CAS  Google Scholar 

  15. Zaleon CR, Guthrie SK. Antipsychotic drug use in older adults. Am J Hosp Pharm 1994; 51: 2917–43

    PubMed  CAS  Google Scholar 

  16. Tinetti ME, Speechley M. Prevention of falls among the elderly. N Engl J Med 1989; 320: 1055–9

    PubMed  CAS  Google Scholar 

  17. Glassman AH, Roose SP. Risks of antidepressants in the elderly: tricyclic antidepressants and arrhythmia-revising risks. Gerontology 1994; 40 Suppl. 1: 15–20

    PubMed  Google Scholar 

  18. Taylor JA, Hanoi GA, Johnson DG, et al. Sympatho-adrenal circulatory regulation of arterial pressure during orthostatic stress in young and older men. Am J Physiol 1992; 263 (2): R1147–85

    PubMed  CAS  Google Scholar 

  19. Luutonen S, Antila K, Erkko M, et al. Haemodynamic response to head-up tilt in elderly hypertensives and diabetics. Age Aging 1995; 24: 315–20

    CAS  Google Scholar 

  20. Kapoor WN. Syncope in older persons. J Am Geriatr Soc 1994; 42: 426–36

    PubMed  CAS  Google Scholar 

  21. Robertson D. Mechanisms of orthostatic hypotension. Curr OpinCardiol 1993; 8: 737–45

    Google Scholar 

  22. Scarpace PJ, Turner N, Mader SL. Beta-adrenergic function in aging: basic mechanisms and clinical implications. Drugs Aging 1991; 1: 116–29

    PubMed  CAS  Google Scholar 

  23. Stumpf JL, Mitrzyk B. Management of orthostatic hypotension. Am J Hosp Pharm 1994; 51: 648–60

    PubMed  CAS  Google Scholar 

  24. Lipsitz LA, Nyquist RP, Wei JY, et al. Post-prandial reduction in blood pressure in the elderly. N Engl J Med 1983; 309: 81–3

    PubMed  CAS  Google Scholar 

  25. Lipsitz LA, Pluchino FC, Wei JY, et al. Cardiovascular and norepinephrine response following meal consumption in elderly persons with post-prandial hypotension and syncope. Am J Cardiol 1986; 58: 810–5

    PubMed  CAS  Google Scholar 

  26. Jansen RWMM, Hoefnagels WHL. Hormonal mechanisms of postprandial hypotension. J Am Geriatr Soc 1991; 39: 1201–7

    PubMed  CAS  Google Scholar 

  27. Tonkin A. Postural hypotension. Med J Aust 1995; 162: 436–8

    PubMed  CAS  Google Scholar 

  28. Walker J, Wynne H. Review: the frequency and severity of adverse drug reactions in elderly people. Age Aging 1994; 23: 255–9

    CAS  Google Scholar 

  29. Mets TF. Drug-induced orthostatic hypotension in older patients. Drugs Aging 1995; 6 (3): 219–28

    PubMed  CAS  Google Scholar 

  30. Sloan RW. Principles of drug therapy in geriatric patients. Clin Pharmacol 1992; 45: 2709–18

    CAS  Google Scholar 

  31. Williams L, Lowenthal DT. Drug therapy in the elderly. South Med J 1992; 85: 127–31

    PubMed  CAS  Google Scholar 

  32. Servin F. Pharmacologie du sujet âgé. Ann Fr Anesth Reanim 1990; 9: 233–6

    PubMed  CAS  Google Scholar 

  33. Durnas C, Loi CM, Cusack BJ. Hepatic drug metabolism and aging. Clin Pharmacokinet 1990; 19: 359–89

    PubMed  CAS  Google Scholar 

  34. Schenker S, Bay M. Drug deposition and hepatotoxicity in the elderly. J Clin Gastroenterol 1994; 18: 232–7

    PubMed  CAS  Google Scholar 

  35. Woodhouse K. Drugs and the liver. Part III. Ageing of the liver and the metabolism of drugs. Biopharm Drug Dispos 1992; 13: 311–20

    PubMed  CAS  Google Scholar 

  36. Schoenberger JA. Drug-induced orthostatic hypotension. Drug Saf 1991; 6: 402–7

    PubMed  CAS  Google Scholar 

  37. Luutonen S, Neuvonen P, Ruskaho H, et al. The role of potassium in postural hypotension: electrolytes and neurohumoral factors in elderly hypertensive patients using diuretics. J Intern Med 1995; 237: 375–80

    PubMed  CAS  Google Scholar 

  38. Piepho RW, Fendler KJ. Antihypertensive therapy in the aged patient: clinical pharmacokinetic considerations. Drugs Aging 1991; 1: 194–211

    PubMed  CAS  Google Scholar 

  39. Abernethy DR, Schwartz JB, Plachetka JR, et al. Comparison in young and elderly patients of pharmacodynamics and disposition of labetalol in systemic hypertension. Am J Cardiol 1987; 60: 697–702

    PubMed  CAS  Google Scholar 

  40. Krum H, Conway EL, Broadbear JH, et al. Postural hypotension in elderly patients given carvedilol. BMJ 1994; 309: 775–6

    PubMed  CAS  Google Scholar 

  41. Purcell H, Waller DG, Fox K. Calcium antagonists in cardiovascular disease. Br J Clin Prac 1989; 43 (10): 369–79

    CAS  Google Scholar 

  42. McAllister RG, Hamann SR, Blouin RA. Pharmacokinetics of calcium-entry blockers. Am J Cardiol 1985; 55 Suppl.: 30B–40B

    PubMed  CAS  Google Scholar 

  43. Robertson DRC, Waller DG, Renwick AG, et al. Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol 1988; 25: 297–305

    PubMed  CAS  Google Scholar 

  44. Schwartz JB, Abernethy DR. Responses to intravenous and oral diltiazem in elderly and younger patients with systemic hypertension. Am J Cardiol 1987; 59: 1111–7

    PubMed  CAS  Google Scholar 

  45. Abernethy DR, Schwartz JB, Todd EL, et al. Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Ann Intern Med 1986; 105: 329–6

    PubMed  CAS  Google Scholar 

  46. Deedwania PC, Cheitlin MD, Das SK, et al. Amlodipine once a day in stable angina: double-blind cross-over comparison with placebo. Clin Cardiol 1993; 16: 599–602

    PubMed  CAS  Google Scholar 

  47. Wei JY. Use of calcium entry blockers in elderly patients. Circulation 1989; 80 Suppl. IV: 171–7

    Google Scholar 

  48. Pool EP, Massie BM, Venkataraman K, et al. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial. Am J Cardiol 1986; 57: 212–7

    PubMed  CAS  Google Scholar 

  49. Markham A, Brogden RN. Diltiazem: a review of its pharmacology and therapeutic use in older patients. Drugs Aging 1993; 3: 363–90

    PubMed  CAS  Google Scholar 

  50. Staessen JA, Celis H, Thijs L. Once-daily antihypertensive treatment with calcium antagonists: Utopia or reality? Med J Neth 1995; 46: 15–24

    CAS  Google Scholar 

  51. Herman AG. Pharmacotherapy with calcium-antagonists: an actualisation. Belg J Med 1995; 51: 119–26

    Google Scholar 

  52. Cagatay M, Frost N, Weiss KH, et al. Assessment of long-term efficacy and tolerability of nisoldipine by the clinical data pool. In: Hugenholtz PG, Meyer J, editors. Nisoldipine. Berlin, Heidelberg: Springer-Verlag, 1987: 201–9

    Google Scholar 

  53. Reid J, Meredith P, Donnelly R, et al. Pharmacokinetics of calcium antagonists. J Cardiovasc Pharmacol 1988; 12: 22S–6S

    Google Scholar 

  54. Koenig W. Efficacy and tolerability of felodipine and amlodipine in the treatment of mild to moderate hypertension. Drug Invest 1993; 5 (4): 200–5

    Google Scholar 

  55. Burges RA, Dodd MG. Amlodipine. Cardiovasc Drug Rev 1990; 8: 25–44

    CAS  Google Scholar 

  56. Opie LH. Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine. Postgrad Med J 1991; 67 Suppl. 5: S2–8

    PubMed  Google Scholar 

  57. Poole-Wilson P. Introduction to the symposium: ‘24-hour protection and control: a new era of calcium antagonists’. J Cardiovasc Pharmacol 1991; Suppl. 1: 17: V–VI

    Google Scholar 

  58. Capewell S, Capewell A. ‘First dose’ hypotension and venodilatation. Br J Clin Pharmacol 1991; 31: 213–5

    PubMed  CAS  Google Scholar 

  59. Guidicelli JF, Berdeaux A, Edouard A, et al. The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br J Clin Pharmacol 1985; 20: 211–8

    Google Scholar 

  60. Webster J. Angiotensin converting enzyme inhibitors in the clinic: first-dose hypotension. J Hypertens 1987; 5 Suppl. 3: 27S–30S

    Google Scholar 

  61. Degaute J-P, Leeman M. Long-term acceptability of perindopril: European multicenter trial on 856 patients. Am J Med 1992; 92 Suppl. 4B: 84S–90S

    PubMed  CAS  Google Scholar 

  62. Kostis JB. Angiotensin converting enzyme inhibitors: pharmacology and clinical use. Am Heart J 1988; 6(1): 1580–605

    Google Scholar 

  63. MacFadyen RJ, Lees KR, Reid JL. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J 1991; 66: 206–11

    PubMed  CAS  Google Scholar 

  64. De Bock V, Mets T, Romagnoli M, et al. Captopril treatment of chronic heart failure in the very old. J Gerontol 1994; 49: M148–152

    PubMed  Google Scholar 

  65. Mets T, De Bock V, Praet JP. First-dose hypotension, ACE inhibition, and heart failure in the elderly [letter]. Lancet 1992; 339: 1487

    PubMed  CAS  Google Scholar 

  66. Cleland JGF, Dargie HJ, McAlphine H, et al. Severe hypotension after first dose of enalapril in heart failure. BMJ 1985; 291: 1309–2

    PubMed  CAS  Google Scholar 

  67. Hasford J, Busmann W-D, Delius W, et al. First dose hypotension with enalapril and prazosin in congestive heart failure. Int J Cardiol 1991; 31: 287–94

    PubMed  CAS  Google Scholar 

  68. MacFadyen RJ, Meredith PA, Elliott HL. Enalapril clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships: an overview. Clin Pharmacokinet 1993; 25: 274–82

    PubMed  CAS  Google Scholar 

  69. Natoff IL, Nixon JS, Francis RJ, et al. Biological properties of the angiotensin-converting enzyme inhibitor cilazapril. J Cardiovasc Pharmacol 1985; 7: 569–80

    PubMed  CAS  Google Scholar 

  70. Deget F, Brogden RN. Cilazapril: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease. Drugs 1991; 41: 799–820

    PubMed  CAS  Google Scholar 

  71. Todd PA, Benfield P. Ramipril: a review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders. Drugs 1990; 1: 110–35

    Google Scholar 

  72. Lees KR, Grenn ST, Reid JL. Influence of age on the pharmacokinetics and pharmacodynamics of perindopril. Clin Pharmacol Ther 1988; 39: 554–8

    Google Scholar 

  73. Wadworth AN, Brogden RN. Quinapril: a review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders. Drugs 1991; 41 (3): 378–99

    PubMed  CAS  Google Scholar 

  74. Canter D, Frank GJ, Knapp LE, et al. The safety profile of quinapril: is there a difference among ACE inhibitors? Clin Cardiol 1990; 13: VII 39–42

    Google Scholar 

  75. Deforrest JM, Waldron TL, Harvey C, et al. Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models. J Cardiovasc Pharmacol 1990; 16: 139–46

    PubMed  CAS  Google Scholar 

  76. Ondetti MA. Structural relationship of angiotensin converting-enzyme inhibitors to pharmacologic activity. Circulation 1988; 77 Suppl. 1: 741–81

    Google Scholar 

  77. Morrison RA, Singhvi SM, Peterson AE, et al. Relative contribution of the gut, liver and lung to the first-pass hydrolysis (bioactivation) of orally administered 14C-fosinopril sodium in dogs: in vitro and in vivo studies. Drug Metab Dispos 1990; 18 (2): 253–7

    PubMed  CAS  Google Scholar 

  78. Singhvi SM, Duchin KL, Morrison RA, et al. Disposition of fosinopril sodium in healthy subjects. Br J Clin Pharmacol 1988; 25: 9–15

    PubMed  CAS  Google Scholar 

  79. Sica DA, Cutler RE, Parmer RJ, et al. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency. Clin Pharmacokinet 1991; 20: 420–7

    PubMed  CAS  Google Scholar 

  80. Hui KK, Duchin KL, Kripalani KJ, et al. Pharmacokinetics of fosinopril in patients with various degrees of renal function. Clin Pharmacol Ther 1991; 49: 457–67

    PubMed  CAS  Google Scholar 

  81. Levinson B, Surgeman A, Copuchan T. Advanced age per se has no influence on the kinetics of the active diacid of fosinopril. J Clin Pharmacol 1986; 26: 555

    Google Scholar 

  82. Begg EJ, Bailey RR, Lynn KL, et al. The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment. J Hypertens 1989; 7 Suppl. 5: 29S–32S

    Google Scholar 

  83. Neubeck M, Fliser D, Pritsch M. Pharmacokinetics and pharmacodynamics of lisinopril in advanced renal failure. Eur J Clin Pharmacol 1994; 46: 537–43

    PubMed  CAS  Google Scholar 

  84. Lindeman RD, Tobin JD, Shock NW. Hypertension and the kidney. Nephron 1987; 47 Suppl. 1: 62–7

    PubMed  Google Scholar 

  85. Frocht A, Fillit H. Renal disease in geriatric patients. J Am Geriatr Soc 1984; 32: 28–43

    PubMed  CAS  Google Scholar 

  86. Fruncillo RJ, Rocci ML, Vlasses PH, et al. Disposition of enalapril and enalaprilat in renal insufficiency. Kidney Int 1987; 31 Suppl. 20: 117S–22S

    Google Scholar 

  87. Kelly JG, Doyle G, Donohue, et al. Acute and chronic dose pharmacokinetics of lisinopril: effects of renal impairment. BMJ 1987;23:629P–30P

    Google Scholar 

  88. Van Schalk BAM, Geyskes GG, Boer P. Lisinopril in hypertensive patients with and without renal failure. Eur J Clin Pharmacol 1987; 32: 11–6

    Google Scholar 

  89. Oster JR, Epstein M. Use of centrally acting sympatholytic agents in the management of hypertension. Arch Intern Med 1991; 151: 1638–44

    PubMed  CAS  Google Scholar 

  90. Robertson D, Goldberg MR, Hollister AS, et al. Clonidine raises blood pressure in severe idiopathic orthostatic hypotension. Am J Med 1983; 74: 193–200

    PubMed  CAS  Google Scholar 

  91. Studer JA, Piepho RW. Antihypertensive therapy in the geriatric patient. II. A review of the alpha1-adrenergic blocking agents. J Clin Pharmacol 1993; 33: 2–13

    PubMed  CAS  Google Scholar 

  92. Weidmann P, Boehlen LM, de Courten M, et al. Antihypertensive therapy in diabetic patients. J Hum Hypertens 1992; 6: 23S–36S

    Google Scholar 

  93. Alpert JS. Nitrate therapy in the elderly. Am J Cardiol 1990; 65: 23J–7J

    PubMed  CAS  Google Scholar 

  94. Kelly JG, O’Malley K. Nitrates in the elderly: pharmacological considerations. Drugs Aging 1992; 2: 14–9

    PubMed  CAS  Google Scholar 

  95. Eichler HG, Hiremath A, Katzir D, et al. Absence of age-related changes in venous responsiveness to nitroglycerin in vivo in humans. Clin Pharmacol Ther 1987; 42: 521–4

    PubMed  CAS  Google Scholar 

  96. Marchionni N, Schneeweiss A, DiBari M, et al. Age-related hemodynamic effects of intravenous nitroglycerin for acute myocardial infarction and left ventricular failure. Am J Cardiol 1988; 61: 81E–3E

    PubMed  CAS  Google Scholar 

  97. Robertson DRC, George CF. Drug therapy for Parkinson’s disease in the elderly. Br Med Bull 1990; 46: 124–46

    PubMed  CAS  Google Scholar 

  98. Evans MA, Triggs EJ, Broe GA, et al. Systemic availability of orally administered levodopa in the elderly Parkinsonian patient. Eur J Clin Pharmacol 1980; 17: 215–21

    PubMed  CAS  Google Scholar 

  99. Robertson DRC, Wood ND, Everest H, et al. The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa. Br J Clin Pharmacol 1989; 28: 61–9

    PubMed  CAS  Google Scholar 

  100. Roose SP, Glassman AH. Cardiovascular effects of tricyclic antidepressants in depressed patient with and without heart disease. J Clin Psychiatry 1989; 50 Suppl.: 1–18

    Google Scholar 

  101. Glassman AH, Preud’homme XA. Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry 1993; 54 Suppl.: 16–22

    PubMed  Google Scholar 

  102. Fernandez F, Levy JK, Lachar BL, et al. The management of depression and anxiety in the elderly. J Clin Psychiatry 1995; 56 Suppl. 2: 20–9

    PubMed  Google Scholar 

  103. Kitanaka I, Ross RJ, Cutler NR, et al. Altered hydroxydesipramine concentrations in elderly depressed patients. Clin Pharmacol Ther 1982; 31:51–5

    PubMed  CAS  Google Scholar 

  104. Abernethy DR, Greenblatt DJ, Shader RI. Imipramine and desipramine disposition in the elderly. J Pharmacol Exp Ther 1985; 232: 183–8

    PubMed  CAS  Google Scholar 

  105. Mendels J. Clinical management of the depressed geriatric patient: current therapeutic options. Am J Med 1993; 94 Suppl. 5A: 13S–8S

    PubMed  CAS  Google Scholar 

  106. Preskorn SH. Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med 1993; 94 Suppl. 5 A: 2S–12S

    PubMed  CAS  Google Scholar 

  107. Preskorn S, Burke M. Somatic therapy for major depressive disorder: selection of an antidepressant. J Clin Psychiatry 1992; 53 Suppl.: 1–14

    Google Scholar 

  108. Doogan DP, Caillard V. Sertraline: a new antidepressant. J Clin Psychiatry 1988; 49 Suppl.: 46–51

    PubMed  Google Scholar 

  109. Rudorfer MV, Potter WZ. Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the ‘newer’ versus the ‘older’ drugs. Drugs 1989; 37: 713–38

    PubMed  CAS  Google Scholar 

  110. Tulloch IF, Johnson AM. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. J Clin Psychiatry 1992; 53 Suppl.: 7–12

    PubMed  Google Scholar 

  111. Christensen P, Thomson HY, Pedersen OL. Orthostatic side-effects of clomipramine and citalopram during treatment for depression. Psychopharmacology 1985; 86: 383–5

    PubMed  CAS  Google Scholar 

  112. Dunner DL. An overview of paroxetine in the elderly. Gerontology 1994; 40 Suppl. 1: 21–7

    PubMed  Google Scholar 

  113. Blumenthal MD, Davie JW. Dizziness and falling in elderly psychiatric outpatients. Am J Psychiatry 1980; 137: 203–6

    PubMed  CAS  Google Scholar 

  114. Rosen J, Bohon S, Gershon S. Antipsychotics in the elderly. Acta Psychiatr Scand 1990; 82 Suppl. 358: 170–5

    Google Scholar 

  115. Steinhart MJ. The use of haloperidol in geriatric patients with organic mental disorder. Curr Ther Res 1983; 33: 132–43

    Google Scholar 

  116. Lipowski ZJ. Delirium in the elderly patient. N Engl J Med 1989; 320: 578–82

    PubMed  CAS  Google Scholar 

  117. Mader SL. Orthostatic hypotension. Med Clin North Am 1989; 73: 1337–49

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Geriatrics, Academic Hospital, Free University of Brussels, Geriatrics, AZ-VUB, Laarbeeklaan 101, B-1090, Brussels, Belgium

    Ilse Verhaeverbeke & Tony Mets

Authors
  1. Ilse Verhaeverbeke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tony Mets
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verhaeverbeke, I., Mets, T. Drug-Induced Orthostatic Hypotension in the Elderly. Drug-Safety 17, 105–118 (1997). https://doi.org/10.2165/00002018-199717020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199717020-00003

Keywords

Search

Navigation